πŸ‡ΊπŸ‡Έ FDA
Patent

US 8404643

Metastin derivatives and use thereof

granted A61KA61K38/00A61P

Quick answer

US patent 8404643 (Metastin derivatives and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Mar 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K38/00, A61P, A61P25/28